ADTXOTCPharmaceutical PreparationsFiscal year ends December 31

Aditxt, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00−0.00 (-16.67%)

Close on Oct 19, 2026

Market cap: $20
P/E (TTM): –
Dividend yield: –

Aditxt, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM Q2 2023 2023-06-30	TTM Q1 2023 2023-03-31	TTM FY 2022 2022-12-31	TTM Q3 2022 2022-09-30	TTM Q2 2022 2022-06-30	TTM Q1 2022 2022-03-31	TTM FY 2021 2021-12-31	TTM Q2 2020 2020-06-30	TTM Q1 2020 2020-03-31	TTM FY 2019 2019-12-31
Revenue	0.01	0.00	0.01	0.01	0.06	0.13	0.21	0.33	0.51	0.65	0.75	0.95	0.94	0.93	–	–	–	–	–	–	–
Cost of Revenue	0.01	0.00	0.07	0.54	0.56	0.63	0.84	0.48	0.64	0.76	0.64	0.77	0.76	0.77	–	–	–	–	–	–	–
Gross Profit	0.00	0.00	-0.07	-0.53	-0.51	-0.49	-0.63	-0.15	-0.14	-0.11	0.11	0.18	0.18	0.17	–	–	–	–	–	–	–
Research & Development	3.03	3.19	3.34	3.16	3.95	11	14	15	14	7.07	5.85	6.52	7.23	7.27	5.89	5.79	5.54	5.04	0.32	0.33	0.18
Selling, General & Admin	–	–	17	18	17	16	15	19	18	19	20	17	14	1.85	4.91	1.15	0.36	0.33	–	–	0.00
Selling & Marketing	–	–	0.51	0.53	0.21	0.20	0.14	0.15	0.24	0.27	1.16	1.11	1.83	1.85	–	–	–	–	–	–	–
General & Administrative	15	16	17	18	17	16	15	18	18	19	19	16	16	16	20	21	22	22	3.21	5.35	5.69
Operating Expenses	18	20	20	22	21	27	30	33	32	26	26	24	25	26	41	42	42	42	3.53	5.68	5.87
Operating Income	-18	-20	-21	-22	-22	-28	-30	-34	-32	-26	-26	-24	-25	-25	-41	-42	-42	-42	-3.53	-5.68	-5.87
Interest Expense	0.55	0.68	0.42	0.81	1.86	4.19	5.96	6.29	5.20	4.20	0.17	-0.07	–	0	–	–	–	0.02	–	–	–
Interest & Investment Income	0.20	0.20	0.26	0.08	0.00	0.00	0.00	0.00	0.00	0.01	0.04	0.05	0.05	0.06	-0.01	0.02	0.02	0.00	–	–	–
Other Non-Operating Income	-35	-23	-23	-3.76	-4.17	-7.16	-10	-9.66	-9.46	-6.33	-3.28	-3.80	-2.43	-2.17	-2.25	-3.77	-4.09	-4.44	-0.27	-0.13	0.04
Pretax Income	-53	-43	-43	-26	-26	-35	-40	-43	-41	-32	-30	-27	-28	-28	-44	-46	-46	-46	–	–	–
Net Income incl. Noncontrolling Interests	-53	-43	-43	-26	-26	-35	-40	-43	-41	-32	–	–	–	–	–	-46	-46	-46	–	–	–
Minority Interest in Earnings	-1.07	-1.07	-0.86	-0.74	-0.68	-0.57	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	-53	-43	-42	-31	-31	-40	-46	-43	-41	-33	-30	-27	-28	-28	-44	-46	-46	-46	-3.80	-5.82	-5.83
Net Income to Common	–	–	–	–	–	–	–	–	–	-33	–	–	-24	-28	–	–	–	–	–	–	–
EPS (Basic)(per share)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-92,389.54	-128,880.34	-152,208.34	-193,888.00	-78,247.58	-120,647.58	-121,600.00
EPS (Diluted)(per share)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-92,389.54	-128,880.34	-152,208.34	-193,888.00	-78,247.58	-120,647.58	-121,600.00
Shares Outstanding (Basic, Weighted)(shares)	–	–	0.54	0.53	0.00	0.00	–	–	–	–	–	–	–	–	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding (Diluted, Weighted)(shares)	–	–	0.54	0.53	0.00	0.00	–	–	–	–	–	–	–	–	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: 19.9%
Operating margin: -127821.4%
Net margin: -372062.4%
Return on equity, FY2025: -1183.4%

Financial strength

Current ratio: 0.06
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 2.0%

Valuation

P/E ratio: –
Price to sales: 0.00
Price to book: –
Dividend yield: –